United States · FDA National Drug Code directory
Lansoprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-112_e1e35404-0cf3-e40d-e053-2995a90a3829
- Product NDC
- 68001-112
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- lansoprazole
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20131201
- Source listing expiry
- 20261231
Source-listed ingredients
- LANSOPRAZOLE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68001-112-03) · 68001-112-03
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68001-112-04) · 68001-112-04
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68001-112-05) · 68001-112-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →